Daniel J. Vis
Daniel J. Vis
Netherlands Cancer Institute, Amsterdam, The Netherlands
Verified email at nki.nl
Title
Cited by
Cited by
Year
Assessment of PLSDA cross validation
JA Westerhuis, HCJ Hoefsloot, S Smit, DJ Vis, AK Smilde, EJJ van Velzen, ...
Metabolomics 4 (1), 81-89, 2008
11482008
A landscape of pharmacogenomic interactions in cancer
F Iorio, TA Knijnenburg, DJ Vis, GR Bignell, MP Menden, M Schubert, ...
Cell 166 (3), 740-754, 2016
9532016
T-profiler: scoring the activity of predefined groups of genes using gene expression data
A Boorsma, BC Foat, D Vis, F Klis, HJ Bussemaker
Nucleic acids research 33 (suppl_2), W592-W595, 2005
2392005
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to P t‐based anti‐cancer drugs
R Planells‐Cases, D Lutter, C Guyader, NM Gerhards, F Ullrich, DA Elger, ...
The EMBO journal 34 (24), 2993-3008, 2015
1572015
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
SN Ooft, F Weeber, KK Dijkstra, CM McLean, S Kaing, E van Werkhoven, ...
Science translational medicine 11 (513), 2019
1502019
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ...
Scientific reports 6 (1), 1-13, 2016
1392016
Selective loss of PARG restores PARylation and counteracts PARP inhibitor-mediated synthetic lethality
E Gogola, AA Duarte, JR de Ruiter, WW Wiegant, JA Schmid, R de Bruijn, ...
Cancer cell 33 (6), 1078-1093. e12, 2018
1292018
Genome-wide analysis of yeast stress survival and tolerance acquisition to analyze the central trade-off between growth rate and cellular robustness
A Zakrzewska, G Van Eikenhorst, JEC Burggraaff, DJ Vis, H Hoefsloot, ...
Molecular biology of the cell 22 (22), 4435-4446, 2011
1252011
Statistical validation of megavariate effects in ASCA
DJ Vis, JA Westerhuis, AK Smilde, J van der Greef
BMC bioinformatics 8 (1), 1-8, 2007
1162007
Intra‐and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
K Kemper, O Krijgsman, P Cornelissen‐Steijger, A Shahrabi, F Weeber, ...
EMBO molecular medicine 7 (9), 1104-1118, 2015
1102015
Dynamic metabolomic data analysis: a tutorial review
AK Smilde, JA Westerhuis, HCJ Hoefsloot, S Bijlsma, CM Rubingh, DJ Vis, ...
Metabolomics 6 (1), 3-17, 2010
1022010
Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites
EJJ van Velzen, JA Westerhuis, JPM van Duynhoven, FA van Dorsten, ...
Journal of proteome research 8 (7), 3317-3330, 2009
992009
Facilitating a culture of responsible and effective sharing of cancer genome data
LL Siu, M Lawler, D Haussler, BM Knoppers, J Lewin, DJ Vis, RG Liao, ...
Nature medicine 22 (5), 464-471, 2016
832016
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models
Z Xue, DJ Vis, A Bruna, T Sustic, S van Wageningen, AS Batra, ...
Cell research 28 (7), 719-729, 2018
562018
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
N Aben, DJ Vis, M Michaut, LF Wessels
Bioinformatics 32 (17), i413-i420, 2016
542016
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
N van Dijk, A Gil-Jimenez, K Silina, K Hendricksen, LA Smit, JM de Feijter, ...
Nature Medicine 26 (12), 1839-1844, 2020
412020
Multilevel models improve precision and speed of IC50 estimates
DJ Vis, L Bombardelli, H Lightfoot, F Iorio, MJ Garnett, LFA Wessels
Pharmacogenomics 17 (7), 691-700, 2016
412016
Identification of a druggable pathway controlling glioblastoma invasiveness
N Pencheva, MC de Gooijer, DJ Vis, LFA Wessels, T Wrdinger, ...
Cell reports 20 (1), 48-60, 2017
362017
P athogenic and targetable genetic alterations in 70 urachal adenocarcinomas
H Reis, KE van der Vos, C Niedworok, T Herold, O Mdos, A Szendrői, ...
International journal of cancer 143 (7), 1764-1773, 2018
192018
Analyzing metabolomics-based challenge tests
DJ Vis, JA Westerhuis, DM Jacobs, JPM van Duynhoven, S Wopereis, ...
Metabolomics 11 (1), 50-63, 2015
182015
The system can't perform the operation now. Try again later.
Articles 1–20